CEA levels in fluids bathing gastrointestinal tumors.

Area of Science:

• Oncology
• Gastroenterology
• Biomarker Discovery

Background:

• Carcinoembryonic antigen (CEA) is a tumor marker often evaluated in plasma for gastrointestinal cancers.
• Early detection of gastrointestinal malignancies is crucial for improved patient outcomes.
• The diagnostic utility of CEA in fluids directly bathing tumors remains less explored compared to plasma.

Purpose of the Study:

• To investigate whether fluids surrounding gastrointestinal tumors contain CEA earlier than plasma.
• To assess the potential of using CEA levels in tumor-bathing fluids as a superior diagnostic marker for gastrointestinal cancers.

Main Methods:

• A controlled prospective study was conducted.
• CEA levels were measured in plasma and tumor-bathing fluids (colonic mucus, gastric juice, duodenal drainage, bile) from patients with gastrointestinal malignancies and healthy controls.
• Comparison of CEA detection rates between plasma and tumor-bathing fluids.

Main Results:

• All patients with colon, gastric, and pancreatic carcinomas showed positive CEA titers in tumor-bathing fluids.
• In contrast, CEA was detected in the plasma of only a subset of these patients (16/23 colon, 6/17 gastric, 4/6 pancreatic).
• CEA was detected in tumor-bathing fluids of 38 out of 46 patients with gastrointestinal malignancies, compared to 26 patients in plasma.

Conclusions:

• CEA is significantly associated with CEA-positive colonic mucus in adenocarcinoma of the colon.
• Assaying CEA in fluids bathing tumors is a potentially more effective method for detecting gastrointestinal malignancies.
• This approach may offer earlier diagnostic insights compared to plasma CEA testing.